Andrology Center
Andrology Center is an India-based diagnostic laboratory specializing in male fertility testing, offering the country's only licensed SCSA DNA fragmentation assay plus a full suite of semen, hormone, and genetic tests through 200+ fertility-center partnerships across 57+ cities.
- Company typePrivate
- Founded-
- HeadquartersCoimbatore, India
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Andrology Center does
Andrology Center is a specialized male fertility diagnostic laboratory headquartered in Coimbatore, Tamil Nadu, India, founded in 2012. The company focuses exclusively on male reproductive health diagnostics, with its flagship offering being the SCSA (Sperm Chromatin Structure Assay) test for measuring sperm DNA fragmentation — a gold-standard assessment in male infertility workups. Under an exclusive licensing partnership with SCSA Diagnostics USA, Andrology Center is the only laboratory in India authorized to perform SCSA testing. The product portfolio extends well beyond SCSA to include AI-powered and manual semen analysis, hormone profiling (Testosterone, FSH, LH, Prolactin), genetic screening (karyotyping, Y-chromosome microdeletion, sperm aneuploidy), infection screening (semen culture, ROS, TB PCR, serology), and thyroid function tests — collectively positioned as a comprehensive male fertility diagnostic panel.
The business operates a centralized diagnostic laboratory model: patient or clinic-collected semen and blood samples are shipped to the Coimbatore facility for analysis, with results typically returned within 24–48 hours. Revenue is generated on a fee-for-service basis per test for referring fertility centers, hospitals, gynecologists, reproductive medicine specialists, and individual patients. The go-to-market motion is B2B-led through a network of 200+ partner fertility centers and hospitals that collect and ship samples, extending service reach to 57+ cities across India despite the single physical lab footprint. Direct-to-patient access is supported via the website, phone, and walk-in appointments at the Coimbatore site. Marketing combines professional referral channels with content-driven digital presence (website, blog, Facebook, Instagram, LinkedIn).
The company is privately held, privately funded (no disclosed investors), and operates with a lean team of approximately 7 employees. Ownership, management team composition, revenue, and corporate history details are not publicly disclosed. The competitive position rests on three pillars: exclusive SCSA licensing, a decade-plus track record in male andrology, and a deeply embedded referral network across India's IVF/fertility ecosystem — though the small headcount and absence of disclosed capital raise signal a niche lifestyle-scale operator rather than a venture-backed growth company.
Andrology Center firmographics
Firmographics- Name
- Andrology Center
- Legal name
- Andrology Center
- Website
- https://andrologycenter.in
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Andrology Center is an India-based diagnostic laboratory specializing in male fertility testing, offering the country's only licensed SCSA DNA fragmentation assay plus a full suite of semen, hormone, and genetic tests through 200+ fertility-center partnerships across 57+ cities.
- Ownership category
- akta.pro rank
Andrology Center industry classification
Industry- Product category
- Andrology Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)
- akta.pro secondary industry
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Andrology Center is headquartered
LocationHeadquarters
- HQ city
- Coimbatore
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Andrology Center business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Diagnostic Testing Services: Fee-for-service laboratory testing model providing specialized male fertility diagnostics. Services include SCSA testing, semen analysis (manual and AI), hormone profiling, genetic screening, and specialized tests like semen culture, ROS testing, and TB PCR. Revenue is generated per test performed for referring fertility centers, hospitals, and individual patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Individual diagnostic tests available for patients and referring fertility centers |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Andrology Center product offering
Product offeringCore offering
Andrology Center operates a centralized diagnostic laboratory providing specialized male fertility testing services, anchored by the SCSA® (Sperm Chromatin Structure Assay) sperm DNA fragmentation test — India's only licensed SCSA® offering under partnership with SCSA Diagnostics USA. The lab delivers a comprehensive male fertility panel including AI-powered and manual semen analysis, hormone profiling, genetic screening (karyotyping, Y-chromosome microdeletion, sperm aneuploidy), infectious/oxidative tests (semen culture, TB PCR, ROS, serology), and thyroid testing, serving referring fertility centers, hospitals, and individual patients via direct and partner-collected sample pathways.
Product overview
Andrology Center is a specialized male fertility diagnostic laboratory offering a comprehensive suite of fertility tests for men. The center's core offering is the SCSA® (Sperm Chromatin Structure Assay) test, which is the gold standard for sperm DNA fragmentation testing and the only licensed SCSA® test in India. Beyond this flagship test, the portfolio includes AI-powered and manual semen analysis, hormonal profiling (Testosterone, FSH, LH, Prolactin), genetic testing (Karyotyping, Y Chromosome Microdeletion, Aneuploidy), infection screening (Semen Culture, Serology, TB PCR), oxidative stress assessment (Semen ROS Test), and thyroid function tests. The center serves patients across 57+ cities in India through collaborations with over 200 fertility centers.
Differentiator
Problem solved
Functional benefit
Products and services
- SCSA® Test (Sperm Chromatin Structure Assay) Gold-standard test for measuring sperm DNA fragmentation index (DFI) and High DNA Stainability (HDS) using flow cytometry with acid denaturation and Acridine Orange staining, providing critical insights into male fertility potential for fertility clinics, reproductive medicine specialists, and individual patients.
- DFI Test (DNA Fragmentation Index) Sperm DNA fragmentation testing service using SCSA® technology to measure the percentage of sperm with damaged DNA, available in 57+ cities across India through sample collection partnerships.
- AI Semen Analysis AI-powered semen analysis using artificial intelligence technology for enhanced precision in measuring sperm count, motility, and morphology beyond conventional manual methods.
- Manual Semen Analysis Traditional semen analysis evaluating sperm count, motility, morphology, and other standard semen parameters.
- Hormone Tests Hormonal profiling including Testosterone, FSH, LH, and Prolactin levels to assess hormonal balance and testicular function affecting sperm production.
- Semen Culture Test Culture-based testing to detect infections or bacterial presence in semen that may affect fertility.
- Semen ROS Test Test measuring Reactive Oxygen Species (ROS) levels in semen to assess oxidative stress and its impact on sperm health.
- Semen TB PCR Polymerase chain reaction test for detecting tuberculosis bacteria in semen, used in diagnosing male genital tuberculosis that may impair fertility.
- Karyotyping Test Chromosomal analysis test to detect chromosomal abnormalities (such as Klinefelter syndrome) that may cause or contribute to male infertility.
- Y Chromosome Microdeletion Test Genetic test detecting small deletions on the Y chromosome (AZF regions) that can disrupt or eliminate sperm production.
- Sperm Aneuploidy Test Test examining chromosomal content in sperm to detect aneuploidies (abnormal chromosome numbers) that may affect embryo development and miscarriage risk.
- Serology Blood Test Blood test for STD screening and infection screening, detecting sexually transmitted infections that may affect fertility.
- Thyroid Tests (TSH, T3 & T4) Thyroid function tests evaluating TSH, T3, and T4 levels to assess thyroid health which impacts male fertility.
Quantifiable outcome
- 200+ fertility centers across India trust Andrology Center for male fertility diagnostics
- +2 more outcomes
Companies that use Andrology Center
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Andrology Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Andrology Center partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- SCSA Diagnostics USAcoreExclusive licensing partnership making Andrology Center the only authorized laboratory in India to perform the SCSA (Sperm Chromatin Structure Assay) test. SCSA Diagnostics USA provides the proprietary testing methodology and validation framework that enables Andrology Center to offer the gold-standard DNA fragmentation test for male fertility assessment.
- 200+ Fertility Centers Across IndiacoreNetwork of over 200 fertility centers and hospitals across India that collaborate with Andrology Center for male fertility diagnostic services. These centers collect patient samples locally and ship to Andrology Center for testing, expanding service reach to 57+ cities. Partnership enables fertility centers to access advanced male factor testing including SCSA DNA fragmentation analysis for their patients.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Andrology Center competitors and assessment
Company assessmentEmerging players
- Legacy: US-based male fertility testing company offering at-home sperm analysis and DNA fragmentation testing. Comparable because it competes for the same male fertility diagnostic workflow, though it focuses on consumer-direct mail-in collection rather than B2B clinic partnerships.
- Fellow: Male fertility diagnostics startup offering mail-in semen analysis with clinical-grade reporting. Comparable because it targets the same male-factor testing workflow Andrology Center serves, with overlapping offerings in semen analysis and STI screening, though operating from the US.
- Sapyen: Australia-based male fertility diagnostic startup offering lab-grade semen analysis through mail-in kits. Comparable because it targets the same male-factor diagnostic decision point, though it operates across a different geographic market.
- Sandstone Diagnostics (Trak Fertility): Developer of at-home male fertility testing products including sperm concentration analysis. Comparable as an emerging male fertility testing company targeting consumer and clinical markets, though focused on lower-cost home testing rather than reference lab diagnostics.
Broad incumbents
- Thyrocare Technologies: High-volume, low-cost Indian diagnostic chain focused on wellness and pathology testing. Comparable as a broad incumbent that could conceivably introduce DFI/SCSA-adjacent testing through partnership or internal R&D, leveraging pan-India sample logistics.
- Metropolis Healthcare: India-wide diagnostic chain providing routine and specialized testing including reproductive hormones and pathology. Comparable as a large incumbent diagnostic network with capacity to add male fertility panels and challenge specialist labs at scale.
- Dr. Lal PathLabs: India's largest diagnostic chain offering thousands of tests including hormone panels and basic semen analysis. Comparable as a broad incumbent that could expand into advanced male fertility diagnostics, threatening Andrology Center's territory from a scaled infrastructure and brand standpoint.
Direct peers
- SCSA Diagnostics USA: Inventor and licensor of the SCSA sperm DNA fragmentation assay that Andrology Center exclusively performs in India. Directly comparable because both operate the same proprietary methodology with clinical interpretation, albeit in different geographies and via a licensing arrangement rather than direct competition.
- ReproSource Fertility Diagnostics: US-based reference laboratory specializing in fertility and reproductive endocrinology diagnostics, including sperm DNA fragmentation testing. Directly comparable as a specialist fertility lab offering advanced male-factor workups that compete for the same clinician mindshare internationally.
Regional players
- Cloudnine Fertility: India-based IVF and maternity hospital chain that purchases andrology diagnostics from specialty labs like Andrology Center. Comparable because as a large fertility chain it could vertically integrate andrology testing, becoming both a customer and a potential competitor in the Indian market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Andrology Center social profiles
Digital presenceAndrology Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Andrology Center leadership team
Management profileNumber of profiles
Andrology Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Andrology Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Andrology Center
What does Andrology Center do?
Andrology Center operates a centralized diagnostic laboratory providing specialized male fertility testing services, anchored by the SCSA® (Sperm Chromatin Structure Assay) sperm DNA fragmentation test — India's only licensed SCSA® offering under partnership with SCSA Diagnostics USA. The lab delivers a comprehensive male fertility panel including AI-powered and manual semen analysis, hormone profiling, genetic screening (karyotyping, Y-chromosome microdeletion, sperm aneuploidy), infectious/oxidative tests (semen culture, TB PCR, ROS, serology), and thyroid testing, serving referring fertility centers, hospitals, and individual patients via direct and partner-collected sample pathways.
Is Andrology Center a public or private company?
Andrology Center is a private company. It is classified as unknown and is currently operating.
When was Andrology Center founded?
Andrology Center was founded in -1. It employs 1 to 10 people.
Where is Andrology Center based?
Andrology Center is headquartered in Coimbatore, India, in the Asia region.
How does Andrology Center make money?
One revenue line is on record: diagnostic Testing Services.
Who are Andrology Center's main competitors?
Emerging players on record are Legacy, Fellow, Sapyen and Sandstone Diagnostics (Trak Fertility). Broad incumbents are Thyrocare Technologies, Metropolis Healthcare and Dr. Lal PathLabs. Direct peers are SCSA Diagnostics USA and ReproSource Fertility Diagnostics. Cloudnine Fertility is listed as a regional player.
Does Andrology Center have an API?
No public API is recorded for Andrology Center.
What industry is Andrology Center in?
Andrology Center's product category is Andrology Diagnostics. Its primary akta.pro industry code is HLAKAOAD, Male Reproductive & Sexual Medicine (Andrology), with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621511 and its SIC code is 8071.